Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding

New England Journal of Medicine

Volumn 345, Issue 9, 2001, Pages 647-655

  Villanueva, Candid ^a   Minana, Josep ^a   Ortiz, Jordi ^a   Gallego, Adolfo ^a   Soriano, German ^a   Torras, Xavier ^a   Sainz, Sergio ^a   Boadas, Jaume ^a   Cusso, Xavier ^a   Guarner, Carlos ^a   Balanzo, Joaquim ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ISOSORBIDE MONONITRATE; NADOLOL;

ADULT; AGED; ARTICLE; ASPIRATION PNEUMONIA; BRADYCARDIA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DYSPNEA; ENDOSCOPIC SURGERY; ESOPHAGUS ULCER; ESOPHAGUS VARICES BLEEDING; FEMALE; HEMODYNAMICS; HIGH RISK PATIENT; HUMAN; LIGATION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SURVIVAL; TREATMENT OUTCOME; VENOUS PRESSURE;

ACTUARIAL ANALYSIS; ADRENERGIC BETA-ANTAGONISTS; DRUG THERAPY, COMBINATION; ENDOSCOPY; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMODYNAMIC PROCESSES; HUMANS; ISOSORBIDE DINITRATE; LIGATION; MALE; MIDDLE AGED; NADOLOL; POSTOPERATIVE COMPLICATIONS; RECURRENCE; REGRESSION ANALYSIS; SURVIVAL ANALYSIS; VASODILATOR AGENTS;

EID: 0035975395     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa003223     Document Type: Article

References (34)

1. The course of patients after variceal hemorrhage
2. Natural history and prognosis of variceal bleeding
3. Portal hypertension and variceal bleeding: An AASLD single topic symposium
4. Long term survival and severe rebleeding after variceal sclerotherapy
5. The treatment of portal hypertension: A meta-analytic review
6. A new endoscopic elastic band ligating device
7. Endoscopic ligation of esophageal varices
8. Endoscopic sderotherapy as compared with endoscopic ligation for bleeding esophageal varices
9. Randomised trial ofvariceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices
10. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices
11. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding: A meta-analysis
12. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: A randomized controlled study
13. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the β-blocker alone
14. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding
15. Multivariate survival analysis using Cox's regression model
16. A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices
17. The economic impact of esophageal variceal hemorrhage: Cost-effectiveness implications of endoscopic therapy
18. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: A prospective, randomized trial
19. Cirrhotics with variceal hemorrhage: The importance of the time interval between admission and the start of analysis for survival and rebleeding rates
20. Definitions, methodology and therapeutic strategies in portal hypertension: A consensus development workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990
21. Pharmacological treatment of portal hypertension: An evidence-based approach
22. Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: Long-term hemodynamic and renal effects
23. Long-term effects of nadolol or nadolol plus isosorbide-5-mononitrate on renal function and ascites formation in patients with cirrhosis
24. Variceal ligation compared with endoscopic sclerotherapy for variceal hemorrhage: Prospective randomized trial
25. A randomised controlled trial comparing wedge pressure guided medical therapy (MT) against variceal banding (VB) in the secondary prevention of variceal haemorrhage
26. Isosorbide mononitrate and propranolol compared with propranolol alone for the prevention of variceal rebleeding
27. Transjugular intrahepatic portosystemic shunt (TIPS) vs propranolol + isosorbide-mononitrate (P+I) for the prevention ofvariceal rebleeding in patients with cirrhosis: Results of a randomized controlled trial
28. Propranolol and isosorbide mononitrate versus sclerotherapy or shunt surgery for the prevention of variceal rebleeding: A randomized trial
29. Complications of cirrhosis. I. Portal hypertension
30. Hemodynamic factors involved in the development and rupture of esophageal varices: A pathophysiologic approach to treatment
31. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage
32. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis